The Valley Desk

NCT00920582 · Interventional trial

Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus

Overall registry status Terminated

Phase 3

Conditions Type 1 Diabetes Mellitus

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov